Citation: Yang Liu, Mengzhu Zheng, Zhilu Ma, Yirong Zhou, Junfeng Huo, Wenbo Zhang, Yu Liu, Yuanyuan Guo, Xuechen Zhou, Hua Li, Lixia Chen. Design, synthesis, and evaluation of PD-L1 degraders to enhance T cell killing activity against melanoma[J]. Chinese Chemical Letters, ;2023, 34(5): 107762. doi: 10.1016/j.cclet.2022.107762 shu

Design, synthesis, and evaluation of PD-L1 degraders to enhance T cell killing activity against melanoma

Yang Liu ^{a, 1} ,
Mengzhu Zheng ^{c, 1} ,
Zhilu Ma ^{c, 1} ,
Yirong Zhou ^c ,
Junfeng Huo ^c ,
Wenbo Zhang ^a ,
Yu Liu ^c ,
Yuanyuan Guo ^a ,
Xuechen Zhou ^c ,
Hua Li ^{a, b, c, *,} ,
Lixia Chen ^{a, *,}

a.
Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China
b.
College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China
c.
School of Pharmacy, Tongji-Rongcheng Center for Biomedicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

li_hua@hust.edu.cn

syzyclx@163.com

Received Date: 11 June 2022
Revised Date: 16 August 2022
Accepted Date: 17 August 2022
Available Online: 20 August 2022

Figures(5)

Inhibitor targeting immune checkpoint is a promising new anticancer therapy. Blocking the interaction between PD-1 and PD-L1 can reverse the immunosuppression state and improve the lethality of immune cells to tumor cells. Here, we report PROTAC-based PD-L1 degraders to enhance T cell killing activity against melanoma. Four series of PD-L1 degraders were designed and synthesized to VHL, CRBN, MDM2 or cIAP E3 ligase system, in which CRBN-ligand-based compound BMS-37-C3 was identified as the most active PROTAC molecule. BMS-37-C3 also significantly enhanced the killing ability of T cells in a co-culture model of A375 and T cells. Furthermore, western blot data and flow cytometry demonstrated that BMS-37-C3 could reduce the protein levels of PD-L1 in dose and time dependent manner, which may provide a new therapeutic method for tumor immunotherapy.
- PD-L1,
- PROTACs,
- BMS-37-C3,
- Immunotherapy,
- Melanoma
1. [1]
  O.J. Finn, Ann. Oncol. 23 (suppl. 8) (2012) ⅷ6–ⅷ9. doi: 10.1093/annonc/mds256
2. [2]
  D.J. Herzyk, H.G. Haggerty, AAPS J. 20 (2018) 28–39. doi: 10.1208/s12248-017-0184-3
3. [3]
  Y.Y. Hu, L. Lin, Z.P. Guo, et al., Chin. Chem. Lett. 32 (2021) 1700–1774.
4. [4]
  V.K. Sondak, K.S. Smalley, R. Kudchadkar, et al., Nat. Rev. Drug Discov. 10 (2011) 411–412. doi: 10.1038/nrd3463
5. [5]
  O. Hamid, C. Robert, A. Daud, et al., N. Engl. J. Med. 369 (2013) 134–144. doi: 10.1056/NEJMoa1305133
6. [6]
  E.B. Garon, N.A. Rizvi, R. Hui, et al., N. Engl. J. Med. 372 (2015) 2018–2028. doi: 10.1056/NEJMoa1501824
7. [7]
  B.C. Pestalozzi, D. Zahrieh, E. Mallon, et al., J. Clin. Oncol. 26 (2008) 3006–3014. doi: 10.1200/JCO.2007.14.9336
8. [8]
  Y.M. Weng, M. Peng, M.X. Hu, et al., OncoTargets Ther. 11 (2018) 7529–7542. doi: 10.2147/ott.s167865
9. [9]
  J.Y. Zhang, Y.Y. Yan, J.J. Li, et al., Front. Pharmacol. 11 (2020) 722–736. doi: 10.3389/fphar.2020.00722
10. [10]
  L.S. Chupak, X. Zheng, Patent, WO2015034820, 2015.
11. [11]
  K. Guzik, K.M. Zak, P. Grudnik, et al., J. Med. Chem. 60 (2017) 5857–5867. doi: 10.1021/acs.jmedchem.7b00293
12. [12]
  B. Cheng, Y. Ren, X. Niu, et al., J. Med. Chem. 63 (2020) 8338–8358. doi: 10.1021/acs.jmedchem.0c00574
13. [13]
  J. Li, L. Wu, W. Yao, Patent, WO2017087777, 2017.
14. [14]
  Z. Shen, X. Sun, Y. Yuan, Patent, CN112724148, 2021.
15. [15]
  I. Hiroyuki, J. Liu, W.Y. Wei, et al., Acta Materia Medica 1 (2022) 24–41.
16. [16]
  J. Salami, C.M. Crews, Science 355 (2017) 1163–1167. doi: 10.1126/science.aam7340
17. [17]
  R.P. Wurz, V.J. Cee, et al., J. Med. Chem. 62 (2019) 445–447. doi: 10.1021/acs.jmedchem.8b01945
18. [18]
  Y. Li, J. Yang, A. Aguilar, et al., J. Med. Chem. 62 (2019) 448–466. doi: 10.1021/acs.jmedchem.8b00909
19. [19]
  K.M. Zak, P. Grudnik, K. Guzik, et al., Oncotarget 7 (2016) 30323–30335. doi: 10.18632/oncotarget.8730
20. [20]
  S.L. Paiva, C.M. Crews, Curr. Opin. Chem. Biol. 50 (2019) 111–119. doi: 10.1016/j.cbpa.2019.02.022
21. [21]
  B. Cheng, Y. Ren, H. Cao, et al., Eur. J. Med. Chem. 199 (2020) 112377. doi: 10.1016/j.ejmech.2020.112377
22. [22]
  Y. Wang, Y. Zhou, S. Cao, et al., Bioorg. Chem. 111 (2021) 10. doi: 10.1117/12.2577847
1. [1]
  Ling Yang , Min Ren , Jie Wang , Liming He , Shanshan Wu , Shuai Yang , Wei Zhao , Hao Cheng , Xiaoming Zhou , Maling Gou . A non-viral gene therapy for melanoma by staphylococcal enterotoxin A. Chinese Chemical Letters, 2024, 35(5): 108822-. doi: 10.1016/j.cclet.2023.108822
2. [2]
  Dexuan Xiao , Tianyu Chen , Tianxu Zhang , Sirong Shi , Mei Zhang , Xin Qin , Yunkun Liu , Longjiang Li , Yunfeng Lin . Transdermal treatment for malignant melanoma by aptamer-modified tetrahedral framework nucleic acid delivery of vemurafenib. Chinese Chemical Letters, 2024, 35(4): 108602-. doi: 10.1016/j.cclet.2023.108602
3. [3]
  Yang Liu , Yan Liu , Kaiyin Yang , Zhiruo Zhang , Wenbo Zhang , Bingyou Yang , Hua Li , Lixia Chen . A selective HK2 degrader suppresses SW480 cancer cell growth by degrading HK2. Chinese Chemical Letters, 2024, 35(8): 109264-. doi: 10.1016/j.cclet.2023.109264
4. [4]
  Chenlu Huang , Xinyu Yang , Qingyu Yu , Linhua Zhang , Dunwan Zhu . Gas-generating polymersomes-based amplified photoimmunotherapy for abscopal effect and tumor metastasis inhibition. Chinese Chemical Letters, 2024, 35(6): 109680-. doi: 10.1016/j.cclet.2024.109680
5. [5]
  Junjie Wang , Yan Wang , Zhengdong Li , Changqiang Xie , Musammir Khan , Xingzhou Peng , Fabiao Yu . Triphenylamine-AIEgens photoactive materials for cancer theranostics. Chinese Chemical Letters, 2024, 35(6): 108934-. doi: 10.1016/j.cclet.2023.108934
6. [6]
  Xinyue Lan , Junguang Liang , Churan Wen , Xiaolong Quan , Huimin Lin , Qinqin Xu , Peixian Chen , Guangyu Yao , Dan Zhou , Meng Yu . Photo-manipulated polyunsaturated fatty acid-doped liposomal hydrogel for flexible photoimmunotherapy. Chinese Chemical Letters, 2024, 35(4): 108616-. doi: 10.1016/j.cclet.2023.108616
7. [7]
  Bohan Chen , Liming Gong , Jing Feng , Mingji Jin , Liqing Chen , Zhonggao Gao , Wei Huang . Research advances of nanoparticles for CAR-T therapy in solid tumors. Chinese Chemical Letters, 2024, 35(9): 109432-. doi: 10.1016/j.cclet.2023.109432
8. [8]
  An Lu , Yuhao Guo , Yi Yan , Lin Zhai , Xiangyu Wang , Weiran Cao , Zijie Li , Zhixia Zhao , Yujie Shi , Yuanjun Zhu , Xiaoyan Liu , Huining He , Zhiyu Wang , Jian-Cheng Wang . Nanomedicine integrating the lipidic derivative of 5-fluorouracil, miriplatin and PD-L1 siRNA for enhancing tumor therapy. Chinese Chemical Letters, 2024, 35(6): 108928-. doi: 10.1016/j.cclet.2023.108928
9. [9]
  Xiaofei NIU , Ke WANG , Fengyan SONG , Shuyan YU . Self-assembly of [Pd₆(L)₄]⁸⁺-type macrocyclic complexes for fluorescent sensing of HSO₃^-. Chinese Journal of Inorganic Chemistry, 2024, 40(7): 1233-1242. doi: 10.11862/CJIC.20240057
10. [10]
  Yu Qin , Mingyang Huang , Chenlu Huang , Hannah L. Perry , Linhua Zhang , Dunwan Zhu . O₂-generating multifunctional polymeric micelles for highly efficient and selective photodynamic-photothermal therapy in melanoma. Chinese Chemical Letters, 2024, 35(7): 109171-. doi: 10.1016/j.cclet.2023.109171
11. [11]
  Jiayu Huang , Kuan Chang , Qi Liu , Yameng Xie , Zhijia Song , Zhiping Zheng , Qin Kuang . Fe-N-C nanostick derived from 1D Fe-ZIFs for Electrocatalytic oxygen reduction. Chinese Journal of Structural Chemistry, 2023, 42(10): 100097-100097. doi: 10.1016/j.cjsc.2023.100097
12. [12]
  Qin Cheng , Ming Huang , Qingqing Ye , Bangwei Deng , Fan Dong . Indium-based electrocatalysts for CO₂ reduction to C1 products. Chinese Chemical Letters, 2024, 35(6): 109112-. doi: 10.1016/j.cclet.2023.109112
13. [13]
  Lei Wan , Yizhou Tong , Xi Lu , Yao Fu . Cobalt-catalyzed reductive alkynylation to construct C(sp)-C(sp³) and C(sp)-C(sp²) bonds. Chinese Chemical Letters, 2024, 35(7): 109283-. doi: 10.1016/j.cclet.2023.109283
14. [14]
  Rong-Nan Yi , Wei-Min He . Photocatalytic Minisci-type multicomponent reaction for the synthesis of 1-(halo)alkyl-3-heteroaryl bicyclo[1.1.1]pentanes. Chinese Chemical Letters, 2024, 35(10): 110115-. doi: 10.1016/j.cclet.2024.110115
15. [15]
  Runze Liu , Yankai Bian , Weili Dai . Qualitative and quantitative analysis of Brønsted and Lewis acid sites in zeolites: A combined probe-assisted 1H MAS NMR and NH3-TPD investigation. Chinese Journal of Structural Chemistry, 2024, 43(4): 100250-100250. doi: 10.1016/j.cjsc.2024.100250
16. [16]
  Min WANG , Dehua XIN , Yaning SHI , Wenyao ZHU , Yuanqun ZHANG , Wei ZHANG . Construction and full-spectrum catalytic performance of multilevel Ag/Bi/nitrogen vacancy g-C₃N₄/Ti₃C₂T_x Schottky junction. Chinese Journal of Inorganic Chemistry, 2024, 40(6): 1123-1134. doi: 10.11862/CJIC.20230477
17. [17]
  Zhen Liu , Zhi-Yuan Ren , Chen Yang , Xiangyi Shao , Li Chen , Xin Li . Asymmetric alkenylation reaction of benzoxazinones with diarylethylenes catalyzed by B(C₆F₅)₃/chiral phosphoric acid. Chinese Chemical Letters, 2024, 35(5): 108939-. doi: 10.1016/j.cclet.2023.108939
18. [18]
  Kai Han , Guohui Dong , Ishaaq Saeed , Tingting Dong , Chenyang Xiao . Morphology and photocatalytic tetracycline degradation of g-C3N4 optimized by the coal gangue. Chinese Journal of Structural Chemistry, 2024, 43(2): 100208-100208. doi: 10.1016/j.cjsc.2023.100208
19. [19]
  Haoran Shi , Jiaxin Wang , Yuqin Zhu , Hongyang Li , Guodong Ju , Lanlan Zhang , Chao Wang . Highly selective α-C(sp³)-H arylation of alkenyl amides via nickel chain-walking catalysis. Chinese Chemical Letters, 2024, 35(7): 109333-. doi: 10.1016/j.cclet.2023.109333
20. [20]
  Tong Li , Leping Pan , Yan Zhang , Jihu Su , Kai Li , Kuiliang Li , Hu Chen , Qi Sun , Zhiyong Wang . Electrochemical construction of 2,5-diaryloxazoles via N–H and C(sp³)-H functionalization. Chinese Chemical Letters, 2024, 35(4): 108897-. doi: 10.1016/j.cclet.2023.108897

Get Citation

PDF

XML

Metrics

PDF Downloads(20)
Abstract views(573)
HTML views(90)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142